150 related articles for article (PubMed ID: 33283460)
1. Targeting Mycobacterium Tuberculosis Enoyl-Acyl Carrier Protein Reductase Using Computational Tools for Identification of Potential Inhibitor and their Biological Activity.
Kuldeep J; Sharma SK; Sharma T; Singh BN; Siddiqi MI
Mol Inform; 2021 May; 40(5):e2000211. PubMed ID: 33283460
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
3. A rational approach to identify inhibitors of Mycobacterium tuberculosis enoyl acyl carrier protein reductase.
Chhabria MT; Parmar KB; Brahmkshatriya PS
Curr Pharm Des; 2013; 19(21):3878-83. PubMed ID: 23477735
[TBL] [Abstract][Full Text] [Related]
4. Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis.
Lone MY; Athar M; Gupta VK; Jha PC
J Mol Graph Model; 2017 Sep; 76():172-180. PubMed ID: 28734205
[TBL] [Abstract][Full Text] [Related]
5. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis.
Chollet A; Stigliani JL; Pasca MR; Mori G; Lherbet C; Constant P; Quémard A; Bernadou J; Pratviel G; Bernardes-Génisson V
Chem Biol Drug Des; 2016 Nov; 88(5):740-755. PubMed ID: 27301022
[TBL] [Abstract][Full Text] [Related]
7. Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking.
Modi P; Patel S; Chhabria MT
J Biomol Struct Dyn; 2019 Apr; 37(7):1736-1749. PubMed ID: 29663870
[TBL] [Abstract][Full Text] [Related]
8. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
9. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN
J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
Holas O; Ondrejcek P; Dolezal M
J Enzyme Inhib Med Chem; 2015; 30(4):629-48. PubMed ID: 25383419
[TBL] [Abstract][Full Text] [Related]
11. Machine learning assisted methods for the identification of low toxicity inhibitors of Enoyl-Acyl Carrier Protein Reductase (InhA).
Chikhale RV; Abdelghani HTM; Deka H; Pawar AD; Patil PC; Bhowmick S
Comput Biol Chem; 2024 Jun; 110():108034. PubMed ID: 38430612
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
Sharma SK; Kumar G; Kapoor M; Surolia A
Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
[TBL] [Abstract][Full Text] [Related]
15. Piperazine derivatives: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase and SAR studies.
Rotta M; Pissinate K; Villela AD; Back DF; Timmers LF; Bachega JF; de Souza ON; Santos DS; Basso LA; Machado P
Eur J Med Chem; 2015 Jan; 90():436-47. PubMed ID: 25461892
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
He X; Alian A; Stroud R; Ortiz de Montellano PR
J Med Chem; 2006 Oct; 49(21):6308-23. PubMed ID: 17034137
[TBL] [Abstract][Full Text] [Related]
17. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
[TBL] [Abstract][Full Text] [Related]
18. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors.
da Silva Lima CH; de Alencastro RB; Kaiser CR; de Souza MV; Rodrigues CR; Albuquerque MG
Int J Mol Sci; 2015 Oct; 16(10):23695-722. PubMed ID: 26457706
[TBL] [Abstract][Full Text] [Related]
19. Structural modification of a novel inhibitor for mycobacterium enoyl-acyl carrier protein reductase assisted by
Taira J; Nagano T; Kitamura M; Yamaguchi M; Sakamoto H; Aoki S
Int J Mycobacteriol; 2020; 9(1):12-17. PubMed ID: 32474482
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
Lu XY; Chen YD; Jiang YJ; You QD
Eur J Med Chem; 2009 Sep; 44(9):3718-30. PubMed ID: 19428156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]